Patients may present with markedly elevated serum PSA, suspicious lesions on mpMRI, and even moderate radiotracer uptake on PSMA PET-CT, leading to a strong but misleading suspicion of high-risk PCa [3,4]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.